IJCDR

Epidermolysis bullosa acquisita (EBA) is a rare, acquired, chronic subepidermal bullous disease of the skin and mucosa characterized by autoantibodies to type VII collagen structures, a major component of anchoring fibrils, that attach the epidermis onto the dermis. The treatment of EBA is based on anecdotal reports in the literature with systemic therapies. We report a case of EBA successfully treated by dapsone.

For more information click here: http://scidoc.org/IJCDR-2332-2977-04-501.php

Dr. Boris NEDELCIUC,

Associate Professor, MD-PhD at Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova

Member of the Editorial Board of the International Journal of Clinical Dermatology & Research, USA

  • Din aceeaşi categorie:

Editorial News: Stevens-Johnson Syndrome Induced by Sorafenib for Hepatocellular Carcinoma – http://e-dermatologie.md/editorial-news-stevens-johnson-syndrome-induced-by-sorafenib-for-hepatocellular-carcinoma/

FacebookTwitterGoogle+Odnoklassnikidistribuie